Preserved Renal-Allograft Function and the PD-1 Pathway Inhibitor Nivolumab

被引：117
作者：
Barnett, Richard [1 ]
Barta, Valerie S. [1 ]
Jhaveri, Kenar D. [1 ]
机构：
[1] Hofstra Northwell Sch Med, Hempstead, NY 11549 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 02期
关键词：
IPILIMUMAB; MELANOMA;
D O I：
10.1056/NEJMc1614298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 192
页数：2
相关论文
共 5 条
[1]   Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center [J].
Horvat, Troy Z. ;
Adel, Nelly G. ;
Thu-Oanh Dung ;
Momtaz, Parisa ;
Postow, Michael A. ;
Callahan, Margaret K. ;
Carvajal, Richard D. ;
Dickson, Mark A. ;
D'Angelo, Sandra P. ;
Woo, Kaitlin M. ;
Panageas, Katherine S. ;
Wolchok, Jedd D. ;
Chapman, Paul B. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28) :3193-+
[2]   Rapamycin: An anti-cancer immunosuppressant? [J].
Law, BK .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 56 (01) :47-60
[3]   Tumor Regression and Allograft Rejection after Administration of Anti-PD-1 [J].
Lipson, Evan J. ;
Bagnasco, Serena M. ;
Moore, Jack, Jr. ;
Jang, Sekwon ;
Patel, Manisha J. ;
Zachary, Andrea A. ;
Pardoll, Drew M. ;
Taube, Janis M. ;
Drake, Charles G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (09) :896-898
[4]   Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial [J].
Margolin, Kim ;
Ernstoff, Marc S. ;
Hamid, Omid ;
Lawrence, Donald ;
McDermott, David ;
Puzanov, Igor ;
Wolchok, Jedd D. ;
Clark, Joseph I. ;
Sznol, Mario ;
Logan, Theodore F. ;
Richards, Jon ;
Michener, Tracy ;
Balogh, Agnes ;
Heller, Kevin N. ;
Hodi, F. Stephen .
LANCET ONCOLOGY, 2012, 13 (05) :459-465
[5]   Role of the PD-1 Pathway in the Immune Response [J].
Riella, L. V. ;
Paterson, A. M. ;
Sharpe, A. H. ;
Chandraker, A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (10) :2575-2587
1